Head and Neck Cancer Trial, Recruiting NCT04428515 Sponsor: Sunnybrook Health Sciences Centre Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT04428515
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with head and neck cancer that has been confirmed by laboratory testing of a tissue or cell sample, has not yet received any first-line treatment, and is planned to be treated with radiotherapy.
  • People whose cancer can be measured by ultrasound or MRI scan done within 28 days before starting treatment.
  • People with a general health and activity level rated as 0 or 1 on a standard medical scale (meaning fully active or able to carry out light work) (confirm with trial site).
  • People with a life expectancy of at least 6 months.
  • People whose blood counts and organ function (bone marrow, liver, and kidneys) fall within required levels based on blood tests taken within 7 days before starting treatment (confirm specific values with trial site).
  • People who are willing and able to give written consent to take part in the study.
  • People who are willing and able to follow the safety procedures required during the scanning period of the trial.

Who may not be able to join:

  • People who have had chemotherapy, radiotherapy, or major surgery within the 4 weeks before joining, or who have not yet recovered from side effects of earlier treatments.
  • People who are currently taking part in another clinical trial involving an experimental treatment.
  • People who have cancer that has spread to the brain.
  • People with a known history of allergic reactions to similar types of compounds or medications used in this trial.
  • People who have medical reasons that prevent them from safely receiving radiotherapy, such as having had previous radiotherapy to the same area, an active connective tissue disease, or a genetic condition that causes unusual sensitivity to radiation.
  • People with a serious active infection that requires antibiotic, antifungal, or antiviral treatment.
  • People with an uncontrolled illness, including an ongoing or active infection.
  • People with certain heart conditions, including heart failure with symptoms, unstable chest pain, or an irregular heartbeat.
  • People with an active, ongoing seizure disorder.
  • People with any unstable health condition that could put their safety at risk or affect their ability to follow the trial requirements.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 April 2019
Est. completion
23 April 2024

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Correlation of response to treatment between photoacoustic parameters and final radiological outcome. measures of outcome.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov